In addition to targeted therapies, BET inhibitor demonstrate potent synergy with immunotherapeutic strategies, reshaping the tumor immune microenvironment and enhancing anti-tumor immunity (Tables 1 and 2). This evidence concerns the gene DNER and neoplasm.